International Medical News Group LLC

SHERPA: Unknown

People

  1. Lichtman
    Lichtman

Groups

  1. Department of Medicine (39)
  2. Solid Tumor Oncology Division (39)
  3. Gynecologic Medicine Service (38)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  5. GSK Faculty (1)
  6. Melanoma and Immunotherapeutics Service (1)
Search Within
Formats
  1. Journal Article (40)
Groups
  1. Department of Medicine (39)
  2. Solid Tumor Oncology Division (39)
  3. Gynecologic Medicine Service (38)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
  5. GSK Faculty (1)
  6. Melanoma and Immunotherapeutics Service (1)
People
  1. Stuart Lichtman (38)
  2. Jedd Wolchok (1)
  3. Karyn Goodman (1)
  4. Paul Chapman (1)
Years
  1. 2015 (1)
  2. 2012 (1)
  3. 2011 (4)
  4. 2010 (4)
  5. 2007 (9)
  6. 2006 (9)

More Years

Publications
  1. The Oncology Report (40)

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Risk stratification appears to be key
    Journal Article

    Goodman, K. A.
    The Oncology Report (2015)

    Fulltext@MSK | Save
  • Second-line bevacizumab adds weeks in metastatic CRC: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2012)

    Fulltext@MSK | Save
  • Neoadjuvant regimen fails to improve surgical outcomes: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • Adjuvant capecitabine 'noninferior' to 5-FU in rectal Ca trial: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • Comment: Most surgical patients tolerate oxaliplatin plus chemoradiation: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • Q and A: New melanoma drugs in community practice
    Journal Article

    Chapman, P.; Wolchok, J.; Sondak, V. K.; Eggermont, A. M. M.
    The Oncology Report (2011)

    Fulltext@MSK | Save
  • BRAF mutation predicts worse survival despite wild-type KRAS: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2010)

    Fulltext@MSK | Save
  • Survival better for CRC patients with liver metastases: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2010)

    Fulltext@MSK | Save
  • Geriatric oncology: Its time has come
    Journal Article

    Lichtman, S.
    The Oncology Report (2010)

    Fulltext@MSK | Save
  • Panitumumab enhances second-line FOLFIRI in phase III: Commentary
    Journal Article

    Lichtman, S. M.
    The Oncology Report (2010)

    Fulltext@MSK | Save

    • International Medical News Group LLC – authorized name for: